NCT07607951Not yet recruiting
Baduanjin Intervention in Clinical Studies After Coronary Revascularization Surgery
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
1. To evaluate the efficacy and safety of the Baduanjin exercise programme in patients following coronary revascularisation surgery; 2. To develop a traditional Chinese medicine (TCM) rehabilitation protocol and evaluation system for patients following coronary revascularisation surgery; 3. To clarify the advantages of TCM rehabilitation in the post-operative management of coronary revascularisation surgery and to provide high-level evidence-based medical evidence for TCM rehabilitation protocols.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 310 (estimated)
- First submitted
- 12 May 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- Liu Qiang
- Diseases
- Coronary artery disease
- NCT number
- NCT07607951
What you commit to
- Study type: Interventional
- Planned participants: 310
- From 1 Jul 2026 to the primary completion date, 30 Jun 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects scheduled to undergo repeat revascularisation surgery in the near future
- Subjects who have participated in a clinical trial involving other drugs or exercise interventions within the past month
Other illness
- Subjects with severe hepatic or renal impairment
- subjects with severe haematological disorders or malignant tumours
- subjects with psychiatric disorders
- subjects with cognitive impairment (e.g. dementia, post-stroke cognitive impairment) that prevents them from understanding or carrying out exercise instructions
- Subjects with other severe cardiovascular diseases such as uncontrolled hypertension, angina pectoris, rapid arrhythmias, high-degree or complete atrioventricular block (without a pacemaker), acute severe aortic stenosis, decompensated heart failure (NYHA Class IV), deep vein thrombosis, obstructive hypertrophic cardiomyopathy, acute pericarditis or myocarditis, acute endocarditis, or acute aortic dissection
- Participants with acute pulmonary embolism or chronic lung disease accompanied by symptoms of dyspnoea (occurring at rest or with minimal exertion)
- Subjects with Shy-Drager syndrome
- Subjects deemed by the investigator to have other conditions rendering them unsuitable for participation in the trial
Other
- subjects with severe electrolyte disturbances
- pregnant or breastfeeding women
- Subjects with impaired limb mobility or who are unable to move independently;
Who the study is looking for
- Participants who meet the diagnostic criteria for coronary heart disease
- Participants who underwent successful percutaneous coronary intervention
- Participants aged between 18 and 80
- Participants of any gender
- Participants who have signed an informed consent form
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.